| pubmed-article:2551462 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2551462 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:2551462 | lifeskim:mentions | umls-concept:C0007776 | lld:lifeskim |
| pubmed-article:2551462 | lifeskim:mentions | umls-concept:C0022655 | lld:lifeskim |
| pubmed-article:2551462 | lifeskim:mentions | umls-concept:C0001613 | lld:lifeskim |
| pubmed-article:2551462 | lifeskim:mentions | umls-concept:C1882598 | lld:lifeskim |
| pubmed-article:2551462 | lifeskim:mentions | umls-concept:C0025912 | lld:lifeskim |
| pubmed-article:2551462 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:2551462 | lifeskim:mentions | umls-concept:C2003941 | lld:lifeskim |
| pubmed-article:2551462 | lifeskim:mentions | umls-concept:C0443199 | lld:lifeskim |
| pubmed-article:2551462 | lifeskim:mentions | umls-concept:C0205191 | lld:lifeskim |
| pubmed-article:2551462 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:2551462 | pubmed:dateCreated | 1989-11-17 | lld:pubmed |
| pubmed-article:2551462 | pubmed:abstractText | Chronic administration of mianserin induced an increase in the density of [3H] prazosin binding sites (23%) in membranes and in the maximal noradrenaline stimulation of phosphoinositide breakdown (81%) in slices from rat brain cortex. In contrast, a similar treatment with protryptiline did not induce any significant changes. These findings suggest that the effects of antidepressant drugs on rat brain cortical alpha 1-adrenoceptors may depend on the characteristics of the drug used. | lld:pubmed |
| pubmed-article:2551462 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2551462 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2551462 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2551462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2551462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2551462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2551462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2551462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2551462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2551462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2551462 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2551462 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:2551462 | pubmed:issn | 0006-8993 | lld:pubmed |
| pubmed-article:2551462 | pubmed:author | pubmed-author:PicatosteFF | lld:pubmed |
| pubmed-article:2551462 | pubmed:author | pubmed-author:ClarkAA | lld:pubmed |
| pubmed-article:2551462 | pubmed:author | pubmed-author:GarcíaAA | lld:pubmed |
| pubmed-article:2551462 | pubmed:author | pubmed-author:BadiaAA | lld:pubmed |
| pubmed-article:2551462 | pubmed:author | pubmed-author:SallésJJ | lld:pubmed |
| pubmed-article:2551462 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2551462 | pubmed:day | 2 | lld:pubmed |
| pubmed-article:2551462 | pubmed:volume | 498 | lld:pubmed |
| pubmed-article:2551462 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2551462 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2551462 | pubmed:pagination | 366-70 | lld:pubmed |
| pubmed-article:2551462 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2551462 | pubmed:meshHeading | pubmed-meshheading:2551462-... | lld:pubmed |
| pubmed-article:2551462 | pubmed:meshHeading | pubmed-meshheading:2551462-... | lld:pubmed |
| pubmed-article:2551462 | pubmed:meshHeading | pubmed-meshheading:2551462-... | lld:pubmed |
| pubmed-article:2551462 | pubmed:meshHeading | pubmed-meshheading:2551462-... | lld:pubmed |
| pubmed-article:2551462 | pubmed:meshHeading | pubmed-meshheading:2551462-... | lld:pubmed |
| pubmed-article:2551462 | pubmed:meshHeading | pubmed-meshheading:2551462-... | lld:pubmed |
| pubmed-article:2551462 | pubmed:meshHeading | pubmed-meshheading:2551462-... | lld:pubmed |
| pubmed-article:2551462 | pubmed:meshHeading | pubmed-meshheading:2551462-... | lld:pubmed |
| pubmed-article:2551462 | pubmed:meshHeading | pubmed-meshheading:2551462-... | lld:pubmed |
| pubmed-article:2551462 | pubmed:meshHeading | pubmed-meshheading:2551462-... | lld:pubmed |
| pubmed-article:2551462 | pubmed:meshHeading | pubmed-meshheading:2551462-... | lld:pubmed |
| pubmed-article:2551462 | pubmed:meshHeading | pubmed-meshheading:2551462-... | lld:pubmed |
| pubmed-article:2551462 | pubmed:meshHeading | pubmed-meshheading:2551462-... | lld:pubmed |
| pubmed-article:2551462 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2551462 | pubmed:articleTitle | Differential effects of chronic treatment with mianserin and protryptiline on rat brain cortical alpha 1-adrenoceptors. | lld:pubmed |
| pubmed-article:2551462 | pubmed:affiliation | Departament de Farmacologia i Psiquiatria, Universitat Autònoma de Barcelona, Spain. | lld:pubmed |
| pubmed-article:2551462 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2551462 | pubmed:publicationType | In Vitro | lld:pubmed |
| pubmed-article:2551462 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2551462 | lld:pubmed |
